SEC Comment Letter 0000000000-26-005324 to ENvue Medical, Inc. (FEED)
ENvue Medical, Inc.
Date: May 26, 2026 · CIK: 0001326706 · Accession: 0000000000-26-005324
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296001
Letter
May 26, 2026 Doron Besser, M.D. Chief Executive Officer ENvue Medical, Inc. 969 Pruitt Avenue Tyler, Texas 77569 Re: ENvue Medical, Inc. Registration Statement on Form S-3 Filed May 18, 2026 File No. 333-296001 Dear Doron Besser, M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Alla Digilova, Esq.
Show Raw Text
May 26, 2026
Doron Besser, M.D.
Chief Executive Officer
ENvue Medical, Inc.
969 Pruitt Avenue
Tyler, Texas 77569
Re: ENvue Medical, Inc.
Registration Statement on Form S-3
Filed May 18, 2026
File No. 333-296001
Dear Doron Besser, M.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and Services
cc: Alla Digilova, Esq.